SGCM
CERE

Sand Grove Capital Management’s Cerevel Therapeutics Holdings, Inc. Common Stock CERE Stock Holding History

Quarter Market Value Status Shares Shares
Change %
Trade Value Portfolio Weight Portfolio Position
2024
Q3
Sell
-919,023
Closed -$37.6M 23
2024
Q2
$37.6M Buy
+919,023
New +$37.6M 10.99% 4